Gessi, Marco <br/><br/>
p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease.  [electronic resource] 

 -  Journal of neuro-oncology  Jan 2012 
 - 135-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7373 
<br/><br/><label>Standard No.: </label>10.1007/s11060-011-0648-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Biomarkers, Tumor<br/>Cerebellar Neoplasms--diagnosis<br/>Child<br/>Child, Preschool<br/>DNA, Neoplasm--biosynthesis<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Neoplastic--genetics<br/>Genes, myc--genetics<br/>Genes, p53--genetics<br/>Humans<br/>Immunohistochemistry<br/>Infant<br/>Male<br/>Medulloblastoma--diagnosis<br/>Mutation<br/>Neoplasm Metastasis--genetics<br/>Point Mutation<br/>Polymorphism, Single-Stranded Conformational<br/>Predictive Value of Tests<br/>Survival Analysis<br/>Young Adult<br/>beta Catenin--genetics